In smaller transactions, ARK sold shares of Adaptive Biotechnologies Corp (NASDAQ: ADPT) and CareDx Inc (NASDAQ: CDNA ), and bought shares of CRISPR Therapeutics AG (NASDAQ: CRSP) and Veracyte Inc ...

The stock is well on its way to building out a cup base that has its all-time high of 125.41 as the buy point. Further, its relative strength line is at a new high on its weekly chart on IBD ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Palantir shares have soared about 1,000% over the last three years as it's launched its popular Artificial Intelligence ...

With shares closing at $115 on Friday and peaking at a record $125 this week, Palantir is now trading at 500 times trailing ...

Shares of Palantir Technologies (PLTR) jumped 8% on Thursday after President Trump announced a new trade deal with the U.K.

After surging more than 300% in 2024, Palantir (PLTR) stock has recently been quite volatile. Valued at a market ...

Palantir stock tumbled Tuesday as investors scrutinized the company's high valuation and declining sales to international ...

Quantum stock market is as uncertain as the field itself, but there are some strong signals investors should not ignore.

Palantir stock fell Friday morning and was set to post a 5% decline for the trading week amid investor concerns about the company's high valuation.

With its shares up 58% year to date, Palantir Technologies (NASDAQ: PLTR) embarrassed its naysayers -- it has been repeatedly ...

On the sell side, ARK offloaded a significant portion of Palantir Technologies Inc (NYSE:NASDAQ: PLTR) stock, divesting ...